PEDBASE.org - The Pediatric Database -
Detailed information of CEREBRAL PRECOCIOUS PUBERTY
CEREBRAL PRECOCIOUS PUBERTY
DEFINITION:
A group of disorders characterized by the orderly development of
secondary sexual characteristics prior to the age of 8 and 8.5 years
in females and males, respectively.
EPIDEMIOLOGY:
- incidence: ?
- age of onset:
- risk factors:
PATHOGENESIS:
- due to the premature awakening of the
hypothalamic-pituitary-gonadal axis by a variety of intracranial
lesions by unknown mechanisms
- considered a true or central (complete) precocious puberty
- gonadotropin-dependent
- development of all secondary sexual characteristics (isosexual)
- increased size and activity of gonads
- the earlier the presentation of true precocious puberty, the
greater the likelihood of an intracranial lesion
2. Etiologic Factors
- hypothalamic hamartoma
- astrocytomas
- ependymomas
- optic gliomas
- pineal teratoma
- tuber cinereum
- ventricular hamartoma
3. Infectious/Inflammatory Lesions
- encephalitis (postencephalitic scars)
- meningitis
- meningoencephalitis (tuberculous)
4. Others
CLINICAL FEATURES:
- development of all secondary sexual characteristics
- increased size and activity of the gonads
2. Hypothalamic Manifestaitons
- adipsia
- cachexia
- diabetes insipidus
- hyperthermia
- obesity
2. Neurological Manifestations
1. Infratentorial
- obstructive hydrocephalus with increased intracranial
pressure
- cerebellar signs
- coning
2. Supratentorial
- focal neurological signs
- personality changes
- seizures
INVESTIGATIONS:
1. Imaging Studies
1. Skeletal X-Rays
2. MRI/CT
3. Pelvic Ultrasound
- enlargement of the uterus
- multicystic appearance of ovaries
2. Serum
- elevated testosterone (M) and estradiol (F)
- elevated FSH and LH on serial determinations
- pulsatile secretion of FSH and LH
- LHRH stimulation test
- brief LH response as in puberty
- best test for evidence of central precocious puberty
MANAGEMENT:
1. Surgery
- treat underlying condition
2. LHRH Analogues
1. Luprolide Acetate (Lupron Depot)
- 0.2-0.3 mg/kg (max. 7.5 mg) IM q4weeks
- suppresses hypothalamic-pituitary-gonadal function
- regression of secondary sexual characteristics
- delays short stature by delaying the closure of epiphyses
and normalizes rate of growth
|
Pediatric Database - CEREBRAL PRECOCIOUS PUBERTY
Pediatric Organization - Pedbase [at] Gmail.com